Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Goldman Sachs Chief U.S"


7 mentions found


A screen displays the Fed rate announcement as a trader works on the floor of the New York Stock Exchange (NYSE), November 2, 2022. Brendan McDermid | ReutersThe U.S. Federal Reserve, European Central Bank and Bank of England are all expected to hike interest rates once again this week, as they make their first policy announcements of 2023. Economists will be watching policymakers' rhetoric closely for clues on the path of future rate hikes this year, as the three major central banks try to engineer a soft landing for their respective economies without allowing inflation to regain momentum. The market is now pricing in this eventuality, but the key question is what the FOMC will indicate about further rate hikes in 2023. "Fewer hikes might be needed if the recent weakening in business confidence captured by the survey data depresses hiring and investment more than we think, substituting for additional rate hikes," Mericle said.
Here are 10 of those names: Two pharma biotech companies made the cut, including Viatris , which has the highest earnings yield on the list. In the banking space, KeyCorp is among the names that should fare well, according to Goldman Sachs. Also on the list is Microchip Technology , which has an 8% earnings yield and 4% estimated earnings growth in 2023. Lastly, Molson Coors Beverage should also outperform amid decelerating inflation, according to Goldman. Molson Coors has an 8% yield and it's estimated earning growth for 2023 is 6%, per Goldman.
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailGoldman Sachs' David Kostin: $3,750-$4,000 is the range you're likely to see for S&PDavid Kostin, Goldman Sachs chief U.S. equity strategist, joins 'Squawk on the Street'' to discuss hedge funds that are leaning towards a bet on a soft landing from inflation.
Watch CNBC's full interview with Goldman Sachs' David Kostin
  + stars: | 2022-11-01 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailWatch CNBC's full interview with Goldman Sachs' David KostinDavid Kostin, Goldman Sachs chief U.S. equity strategist, joins 'Squawk on the Street' to discuss what the markets are suggesting, if his odds of a hard landing from inflation have changed and more.
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailEquity markets suggest they're overvalued and have more downside risk, says Goldman's KostinDavid Kostin, Goldman Sachs chief U.S. equity strategist, joins 'Squawk on the Street' to discuss what the markets are suggesting, if his odds of a hard landing from inflation have changed and more.
Watch CNBC's full interview with Goldman Sach's David Kostin
  + stars: | 2022-10-11 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailWatch CNBC's full interview with Goldman Sach's David KostinDavid Kostin, Goldman Sachs chief U.S. equity strategist, joins 'Squawk on the Street' to discuss earnings growth estimates for Q4, increased interest rates being priced in to the market, and the likelihood of a soft landing rather than a recession.
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailWe are looking for roughly 8% growth this year, says Goldman's David KostinDavid Kostin, Goldman Sachs chief U.S. equity strategist, joins 'Squawk on the Street' to discuss earnings growth estimates for Q4, increased interest rates being priced in to the market, and the likelihood of a soft landing rather than a recession.
Total: 7